Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 000, Number 000, May 2026, pages 000-000


Pregnancy After In Vitro Fertilization in Budd–Chiari Syndrome Secondary to Polycythemia Vera: Multidisciplinary Management and Perioperative Considerations

Table

↓  Table 1. Chronological Clinical Course Summarizing Key Events, Findings, and Management Decisions From Pre-Conception to Postpartum
 
Time period/gestational ageClinical eventKey findingsManagement/interventions
AFP: alpha-fetoprotein; BCS: Budd–Chiari syndrome; ICP: intrahepatic cholestasis of pregnancy; IVF: in vitro fertilization; LMWH: low-molecular-weight heparin; MELD: Model for End-Stage Liver Disease; MRI: magnetic resonance imaging; OHSS: ovarian hyperstimulation syndrome; PV: polycythemia vera; UDCA: ursodeoxycholic acid.
Pre-conception periodKnown Budd–Chiari syndrome and polycythemia veraChronic hepatic venous outflow obstructionLong-term anticoagulation; hepatology and hematology follow-up
Early pregnancy (post-IVF conception)IVF pregnancy complicated by OHSSAscitesLMWH; monitoring
Third trimesterProgression to severe ICP and portal hypertension; Decision for planned early deliveryElevated bile acids; rising bilirubin; thrombocytopeniaUDCA therapy; Intensified surveillance; multidisciplinary decision for preterm cesarean section
DeliveryPreterm cesarean sectionHigh maternal risk due to BCS, PV, severe ICP, portal hypertensionPerioperative terlipressin; regional anesthesia; close monitoring
Immediate postpartum periodUncomplicated recoveryNo hemorrhagic or thrombotic eventsContinuation of LMWH; standard postpartum care
Postpartum follow-upLong-term hepatic evaluationMRI: cirrhotic-pattern changes; MELD 15; mildly elevated AFPHepatology follow-up; ongoing surveillance